We're going to check out a few of the best picks from our screener tool. Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization of ...

Earnings call BioGaia delivered 7% reported sales growth (14% organic, excluding currency) in Q3, with EBIT margin expanding to 26% from 14% YoY due to geographic mix and margin improvements.

BioGaia AB’s annual general meeting approved the 2025 financial statements, discharged the board and CEO from liability, and confirmed Deloitte AB as auditor, while maintaining a six-member board with ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An ...

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Results from a randomized, controlled pilot study in 76 infants with acute diarrhoea show that rapid diagnostic testing and Lactobacillus reuteri ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Prior to the new review seven meta-analyses, evaluating different probiotics as well as non-probiotic treatments, have come to the same conclusion; that L.

(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2024, BioGaia reports growth across all regions with stronger performance in Americas and stronger ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Infant Bacterial Therapeutics (IBT), a subsidiary of BioGaia, today announced that the IND (Investigational New Drug) for the prevention of necrotizing enterocolitis (NEC), has been accepted by the ...

FIRST QUARTER 2026 Net sales amounted to SEK 372.6 million (366.3), an increase of SEK 6.3 million, an increase excluding currency effects of 15% (2% including currency effects). Net sales in the Pedi ...